retatrutide parkinson clinical trial Parkinson's drug pipeline evolution and future directions | Michael S Okun posted on the topic Retatrutide—A Game Changer in Obesity
Description
1 GLP-1 RAs should be titrated until A1C goal, maximum dose, or patient tolerability has been met
There is not a known, singular cause, but individuals with a particular gene, HLA-B27 , have an increased risk of developing the condition
Pharmacother: J Human Pharmacol Drug Therapy
However, because GLP-1 receptor agonists slow gastric emptying and alter gastrointestinal motility, patients without a gallbladder may notice different digestive sensations compared to those with an intact biliary system
B., Jacob J., Kao W
Consult your doctor before you take any new medication
